Navigation Links
Isis Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2011
Date:9/1/2011

CARLSBAD, Calif., Sept. 1, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at Stifel Nicolaus' Healthcare Conference 2011 on Thursday, September 08, 2011 at 2:05 p.m. ET at the Four Seasons Hotel in Boston.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 24 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, mipomersen following regulatory approval, which is expected in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
2. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. Vanda Pharmaceuticals to Participate in Stifel Nicolaus Global Healthcare Conference and Jefferies Fall 2011 Mid-Atlantic Corporate Access Day
5. Auxilium Pharmaceuticals, Inc. and BioSpecifics Technologies Corp. Announce Plans to Develop Additional Indications using XIAFLEX®
6. Onyx Pharmaceuticals Appoints Dr. Helen Torley as Chief Commercial Officer
7. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
8. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
9. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference In New York
10. Syndax Pharmaceuticals to Present at Upcoming Fall Financial Conferences
11. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , August 28, 2014 ... Market Research "Radiofrequency Identification (RFID) Market (Tags, Readers, Middleware, ... Growth, Trends and Forecast, 2014 - 2020" the global ... billion in 2013 and is expected to grow at ... reach an estimated value of USD 5.3 billion in ...
(Date:8/28/2014)... -- In recognition of the increased risks that seniors ... pneumonia, shingles and other illnesses, CVS/pharmacy ® ... be Senior Vaccination Month. Because people,s immune systems ... adults ages 65 years and older stay up ... MinuteClinic nurse practitioners and physician assistants will be ...
(Date:8/28/2014)... , Aug. 28, 2014   Venaxis, Inc.  (Nasdaq: ... on obtaining FDA clearance for and commercializing its CE ... for aiding in identifying children, adolescent, and young adult ... risk for appendicitis, today announced it will present at ... th Annual Global Investment Conference being held in ...
Breaking Medicine Technology:Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 2Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 3Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 4Radiofrequency Identification (RFID) Market in Healthcare is Expected to Reach USD 5.3 Billion Globally by 2020: Transparency Market Research 5September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3
... CHAPEL HILL, N.C., US, March 06, 2007,/PRNewswire/ ... and,Lantibio, Inc. ("Lantibio") today announced positive final ... clinical,study of Moli1901, an experimental compound to ... by AOP Orphan in,Europe under a licensing ...
... 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's leading ... trials of BL-1040 demonstrating that,BL-1040 is effective ... myocardial infarction (MI), thereby reducing left ventricle,dilatation ... model. Professor,Jonathan Leor, MD, Director of the ...
Cached Medicine Technology:AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
(Date:8/28/2014)... of women who are given information about the chance ... not fully understand the risks involved, according to research ... , today (Friday). , In a survey of around ... London (UCL) found that 64 per cent felt they ... chance that screening will pick up cancers that would ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group ... September. This month will be a celebration of ... health services. Along with other treatment facilities and ... to spread the word about this national observance. ... the work of treatment and recovery professionals, and ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment Group ... users in the workplace. A recent report from ... states that drug abuse is costing employers an ... or are addicted to drugs affect their employers and ... over into the workplace, causing expensive problems for their ...
(Date:8/28/2014)... Reinberg HealthDay Reporter THURSDAY, ... the diet may worsen symptoms of multiple sclerosis (MS), a ... MS, such as vitamin D, smoking and Epstein Barr virus ... another environmental factor affecting MS patients," said lead researcher Dr. ... in Buenos Aires. Multiple sclerosis is a disease of ...
(Date:8/28/2014)... 28, 2014 Testimony began this ... a transvaginal mesh lawsuit ( http://www.transvaginalmeshlawsuithelp.com/ )involving ... LLP reports. Court documents pending in the U.S. ... that the case was filed on behalf of ... surgeries, allegedly due to vaginal mesh complications associated ...
Breaking Medicine News(10 mins):Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: Testimony Begins in Second Federal Ethicon Bellwether Trial, Bernstein Liebhard LLP Reports 4
... risk when taking nortriptyline than escitalopram, study finds , ... the antidepressant nortriptyline (Aventyl) are nearly 10 times more ... the antidepressant escitalopram (Lexapro, Cipralex), a new study has ... BMC Medicine , included 811 people with ...
... 13 , News facts: , ... community for individuals with breast cancer, however the experiences of ... stage of the disease, is rarely discussed., MBC, also ... occurs when cancer has spread beyond the breast to other ...
... Md., Oct. 15 The U.S. Food and Drug ... purchasing any products over the Internet that claim to ... The warning comes after the FDA recently purchased and ... may pose risks to patients. , (Logo: ...
... Oct. 15 Mayo Clinic clinicians and designers, along ... a tool to involve patients more in their diabetes ... decision aid cards, could help patients make decisions involving ... results of this randomized trial are in September,s issue ...
... With national focus on health reform, NY hospital system looks to ... area,s largest automated medical record system , GREAT NECK, ... it is subsidizing up to 85 percent of the cost of ... offices of its more than 7,000 affiliated physicians in New York ...
... will host "S,more to Love", a cocktail fundraiser on Friday, November ... benefit Birch Family Camp. , Celebrating its 20th year, the Birch ... the 5 boroughs of NYC, along with 200 volunteers for a ... located in the Hudson Valley. Throughout the year this community ...
Cached Medicine News:Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 2Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 3Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 2Health News:FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the Internet 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 2Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 3Health News:Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 4Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 2Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 3Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 4Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 5Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 6Health News:North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System 7Health News:One Heartland Hosting: S'more to Love Cocktail Fundraiser 2
... specifically for detection of recent-onset neovascular ("wet") ... maps and quantifies visual field defects consistent ... to the wet stage of the disease. ... for small visual field defects, the PreView ...
... a new functional test which exhibits 100% ... C Resistance caused by the Factor V ... commercially available methods, Pefakit APC-R FVL shows ... Lupus Anticoagulants, Elevated FVIII levels, Heparins or ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
Medicine Products: